Kalvista Pharmaceuticals Stock Price Prediction
| KALV Stock | USD 9.33 0.01 0.11% |
Oversold Vs Overbought
46
Oversold | Overbought |
EPS Estimate Current Year (3.06) | EPS Estimate Next Year (2.56) | Wall Street Target Price 29.1667 | EPS Estimate Current Quarter (0.91) | Quarterly Revenue Growth 0.307 |
Using Kalvista Pharmaceuticals hype-based prediction, you can estimate the value of Kalvista Pharmaceuticals from the perspective of Kalvista Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Kalvista Pharmaceuticals using Kalvista Pharmaceuticals' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Kalvista using crowd psychology based on the activity and movement of Kalvista Pharmaceuticals' stock price.
Kalvista Pharmaceuticals Implied Volatility | 1.6 |
Kalvista Pharmaceuticals' implied volatility exposes the market's sentiment of Kalvista Pharmaceuticals stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Kalvista Pharmaceuticals' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Kalvista Pharmaceuticals stock will not fluctuate a lot when Kalvista Pharmaceuticals' options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Kalvista Pharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying Kalvista because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Kalvista Pharmaceuticals after-hype prediction price | USD 9.48 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Kalvista |
Kalvista Pharmaceuticals After-Hype Price Prediction Density Analysis
As far as predicting the price of Kalvista Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Kalvista Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Kalvista Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Kalvista Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Kalvista Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Kalvista Pharmaceuticals' historical news coverage. Kalvista Pharmaceuticals' after-hype downside and upside margins for the prediction period are 4.75 and 14.21, respectively. We have considered Kalvista Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Kalvista Pharmaceuticals is somewhat reliable at this time. Analysis and calculation of next after-hype price of Kalvista Pharmaceuticals is based on 3 months time horizon.
Kalvista Pharmaceuticals Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Kalvista Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Kalvista Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Kalvista Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.43 | 4.73 | 0.15 | 0.10 | 10 Events / Month | 4 Events / Month | In about 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
9.33 | 9.48 | 1.61 |
|
Kalvista Pharmaceuticals Hype Timeline
Kalvista Pharmaceuticals is now traded for 9.33. The entity has historical hype elasticity of 0.15, and average elasticity to hype of competition of 0.1. Kalvista is expected to increase in value after the next headline, with the price projected to jump to 9.48 or above. The average volatility of media hype impact on the company the price is over 100%. The price increase on the next news is projected to be 1.61%, whereas the daily expected return is now at -0.43%. The volatility of related hype on Kalvista Pharmaceuticals is about 2071.53%, with the expected price after the next announcement by competition of 9.43. Net Loss for the year was (126.64 M) with loss before overhead, payroll, taxes, and interest of (80.28 M). Given the investment horizon of 90 days the next expected press release will be in about 10 days. Check out Kalvista Pharmaceuticals Basic Forecasting Models to cross-verify your projections.Kalvista Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to Kalvista Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Kalvista Pharmaceuticals' future price movements. Getting to know how Kalvista Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Kalvista Pharmaceuticals may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ZVSA | ZyVersa Therapeutics | (0.01) | 5 per month | 0.00 | (0.14) | 9.17 | (10.36) | 78.93 | |
| SONN | Sonnet Biotherapeutics Holdings | 1.15 | 7 per month | 0.00 | (0.13) | 12.31 | (9.79) | 37.58 | |
| ZURA | Zura Bio Limited | 0.03 | 9 per month | 0.00 | (0.05) | 7.95 | (7.94) | 30.69 | |
| PHIO | Phio Pharmaceuticals Corp | 0.18 | 6 per month | 0.00 | (0.05) | 11.78 | (10.38) | 36.22 | |
| RNAZ | Transcode Therapeutics | 0.04 | 2 per month | 6.52 | 0.07 | 22.00 | (11.43) | 68.80 | |
| QNRX | Quoin Pharmaceuticals Ltd | (0.02) | 9 per month | 6.73 | 0.05 | 17.65 | (9.68) | 74.46 |
Kalvista Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Kalvista price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Kalvista using various technical indicators. When you analyze Kalvista charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Kalvista Pharmaceuticals Predictive Indicators
The successful prediction of Kalvista Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Kalvista Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Kalvista Pharmaceuticals based on analysis of Kalvista Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Kalvista Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Kalvista Pharmaceuticals's related companies. | 2020 | 2023 (projected) | Graham Number | 26.57 | 20.86 | Receivables Turnover | 1.22 | 1.4 |
Story Coverage note for Kalvista Pharmaceuticals
The number of cover stories for Kalvista Pharmaceuticals depends on current market conditions and Kalvista Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Kalvista Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Kalvista Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Kalvista Pharmaceuticals Short Properties
Kalvista Pharmaceuticals' future price predictability will typically decrease when Kalvista Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Kalvista Pharmaceuticals often depends not only on the future outlook of the potential Kalvista Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Kalvista Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 36.8 M | |
| Cash And Short Term Investments | 210.4 M |
Additional Tools for Kalvista Stock Analysis
When running Kalvista Pharmaceuticals' price analysis, check to measure Kalvista Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kalvista Pharmaceuticals is operating at the current time. Most of Kalvista Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Kalvista Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kalvista Pharmaceuticals' price. Additionally, you may evaluate how the addition of Kalvista Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.